The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...
A recent announcement by Eli Lilly suggests that the company understands the economic conundrum some patients face. Per a ...
Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it said Tuesday, in a move to expand access and ease supply constraints ...
People who are in need of weight loss medications but do not have insurance coverage will soon have a new way to access one ...
Lilly clearly has an abundance of growth drivers -- and the list includes more than Mounjaro, Zepbound, and the six drugs ...
Eli Lilly's weight loss treatment Zepbound might be a blockbuster in the making, but it wasn't without its challenges. See ...
1. Expand Healthy Options: Increase your assortment of low-calorie and high-protein products, such as protein bars and ...
Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial public offering in the United States, according to a regulatory filing.